7,828
Views
22
CrossRef citations to date
0
Altmetric
Oncology

Bioinformatics reveal macrophages marker genes signature in breast cancer to predict prognosis

ORCID Icon, , &
Pages 1020-1032 | Received 07 Dec 2020, Accepted 03 Apr 2021, Published online: 30 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ruijuan Wang, Huanhong Zeng, Xueming Xiao, Junjie Zheng, Naizhuo Ke, Wenjun Xie, Qiang Lin & Hui Zhang. (2023) Identification of prognostic biomarkers of breast cancer based on the immune-related gene module. Autoimmunity 56:1.
Read now

Articles from other publishers (21)

Zhijia Zhao, Yuan Huo, Yufeng Du, Yanan Huang, Hongchen Liu, Chengtao Zhang & Jinsong Yan. (2024) A neutrophil extracellular trap-related risk score predicts prognosis and characterizes the tumor microenvironment in multiple myeloma. Scientific Reports 14:1.
Crossref
Andrea Nicolini & Paola Ferrari. (2024) Targeted Therapies and Drug Resistance in Advanced Breast Cancer, Alternative Strategies and the Way beyond. Cancers 16:2, pages 466.
Crossref
Zhihao Zhao, Qilin Wang, Fang Zhao, Junnan Ma, Xue Sui, Hyok Chol Choe, Peng Chen, Xue Gao & Lin Zhang. (2024) Single-cell and transcriptomic analyses reveal the influence of diabetes on ovarian cancer. BMC Genomics 25:1.
Crossref
Na Wu, Jingyi Chen, Tingru Lin, Zhaohui Zhong, Mei Li, Yimeng Yu, Jingzhu Guo & Weidong Yu. (2023) Identification of AP002498.1 and LINC01871 as prognostic biomarkers and therapeutic targets for distant metastasis of colorectal adenocarcinoma. Cancer Medicine 13:1.
Crossref
Haihong Hu, Mingxiang Zou, Hongjuan Hu, Zecheng Hu, Lingxiang Jiang, David Escobar, Hongxia Zhu, Wendi Zhan, Ting Yan & Taolan Zhang. (2023) A breast cancer classification and immune landscape analysis based on cancer stem-cell-related risk panel. npj Precision Oncology 7:1.
Crossref
Ye Shen, Lianming Zhou, Meiyu Xu, Zhanhai Tan, Kai Yao & Wenjie Wang. (2023) MED1 induces M2 polarization of tumor-associated macrophages to aggravate breast cancer. Genes & Genomics 45:12, pages 1517-1525.
Crossref
Jia Hu, Yun Wu, Xiaoping Dong, Yong Zeng & Yongjun Wang. (2023) The Diagnostic and Prognostic Value of Neurotransmitter Receptor-Related Genes in Colon Adenocarcinoma. Molecular Biotechnology.
Crossref
Xuejing Shi, Baoqiang Xiao & Rui Feng. (2023) Identification of a glycolysis-related miRNA Signature for Predicting Breast cancer Survival. Molecular Biotechnology.
Crossref
Zundong Liu, Mingji Ding, Pengjun Qiu, Kelun Pan & Qiaonan Guo. (2023) Natural killer cell-related prognostic risk model predicts prognosis and treatment outcomes in triple-negative breast cancer. Frontiers in Immunology 14.
Crossref
Xiaoyu Mao, Fanglong Song, Ju Jin, Bin Zou, Peijun Dai, Mingjuan Sun, Weicheng Xu, Lianghua Wang & Yifan Kang. (2023) Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma. Frontiers in Immunology 14.
Crossref
Yuxin Man, Chao Dai, Qian Guo, Lingxi Jiang & Yi Shi. (2023) A novel PD-1/PD-L1 pathway molecular typing-related signature for predicting prognosis and the tumor microenvironment in breast cancer. Discover Oncology 14:1.
Crossref
Jiayin Yu, Mingyao Lai, Zhaoming Zhou, Jiangfen Zhou, Qingjun Hu, Juan Li, Hainan Li, Longhua Chen, Lei Wen, Meijuan Zhou & Linbo Cai. (2023) The PTEN-associated immune prognostic signature reveals the landscape of the tumor microenvironment in glioblastoma. Journal of Neuroimmunology 376, pages 578034.
Crossref
Soledad Ochoa & Enrique Hernández-Lemus. (2023) Functional impact of multi-omic interactions in breast cancer subtypes. Frontiers in Genetics 13.
Crossref
Irina Larionova & Liubov Tashireva. (2023) Immune gene signatures as prognostic criteria for cancer patients. Therapeutic Advances in Medical Oncology 15.
Crossref
Youngbin Cho, Ruxuan Li & Ioannis K. Zervantonakis. 2023. Engineering and Physical Approaches to Cancer. Engineering and Physical Approaches to Cancer 201 229 .
Raihanul Bari Tanvir, Masrur Sobhan & Ananda Mohan Mondal. (2022) An Autoencoder Based Bioinformatics Framework for Predicting Prognosis of Breast Cancer Patients. An Autoencoder Based Bioinformatics Framework for Predicting Prognosis of Breast Cancer Patients.
Xiaomin Wang, Yiwei Xu, Qi Sun, Xintong Zhou, Wenzhe Ma, JiBiao Wu, Jing Zhuang & Changgang Sun. (2022) New insights from the single-cell level: Tumor associated macrophages heterogeneity and personalized therapy. Biomedicine & Pharmacotherapy 153, pages 113343.
Crossref
Kai-yu Shen, Bin-yu Chen & Wen-cang Gao. (2022) Single-Cell RNA Sequencing Reveals the Role of Epithelial Cell Marker Genes in Predicting the Prognosis of Colorectal Cancer Patients. Disease Markers 2022, pages 1-26.
Crossref
Peng Song, Wenbin Li, Lei Guo, Jianming Ying, Shugeng Gao & Jie He. (2022) Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing. Frontiers in Immunology 13.
Crossref
Yi Yang, Hong-Li Liu & Yi-Jing Liu. (2022) A Novel Five-Gene Signature Related to Clinical Outcome and Immune Microenvironment in Breast Cancer. Frontiers in Genetics 13.
Crossref
Jie Zhu, Weikaixin Kong, Liting Huang, Shixin Wang, Suzhen Bi, Yin Wang, Peipei Shan & Sujie Zhu. (2022) MLSP: A bioinformatics tool for predicting molecular subtypes and prognosis in patients with breast cancer. Computational and Structural Biotechnology Journal 20, pages 6412-6426.
Crossref